Solv Endotherapy Overview

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 3

Solv Endotherapy General Information

Description

Developer of drug-device combo technology designed for the treatment of acute pancreatitis complications. The company's technology offers therapeutic dissolution systems, enabling healthcare providers to rapidly and safely bring resolution to severe medical conditions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Pasadena, CA
  • United States
Primary Industry
Other Devices and Supplies
Other Industries
Drug Delivery
Vertical(s)
Corporate Office
  • Pasadena, CA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Solv Endotherapy Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator Completed Startup
2. Accelerator/Incubator Completed Startup
1. University Spin-Out Completed Startup
To view Solv Endotherapy’s complete valuation and funding history, request access »

Solv Endotherapy Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Johns Hopkins Technology Ventures Accelerator/Incubator
Johns Hopkins University University
Monarc Partners Accelerator/Incubator
To view Solv Endotherapy’s complete investors history, request access »

Solv Endotherapy FAQs

  • Where is Solv Endotherapy headquartered?

    Solv Endotherapy is headquartered in Pasadena, CA.

  • What industry is Solv Endotherapy in?

    Solv Endotherapy’s primary industry is Other Devices and Supplies.

  • Is Solv Endotherapy a private or public company?

    Solv Endotherapy is a Private company.

  • What is Solv Endotherapy’s current revenue?

    The current revenue for Solv Endotherapy is .

  • Who are Solv Endotherapy’s investors?

    Johns Hopkins Technology Ventures, Johns Hopkins University, and Monarc Partners have invested in Solv Endotherapy.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process